Caredx earnings were $111.0M for the trailing 12 months ending Jun 30, 2026, with 92% growth year over year. The latest CDNA earnings report on Jun 30, 2026 announced Q2 2026 earnings of $110.6M, up 3,838.6% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, CDNA reported annual earnings of -$21.4M, with -140.6% growth.
CDNA past earnings growth
How has CDNA's earnings growth performed historically?
On CDNA's earnings call on Jul 30, 2026, Caredx (NASDAQ: CDNA) reported Q2 2026 earnings per share (EPS) of $2.15, up 1,443.75% year over year. Total CDNA earnings for the quarter were $110.64 million. In the same quarter last year, Caredx's earnings per share (EPS) was -$0.16.
As of the last Caredx earnings report, Caredx is currently profitable. Caredx's net profit (also called net income) for the twelve months ending Jun 30, 2026 was $111.01 million, a 90.94% increase year over year.
What was CDNA's earnings growth in the past year?
As of Caredx's earnings date in Jul 30, 2026, Caredx's earnings has grown 91.96% year over year. This is 82.54 percentage points higher than the US Diagnostics & Research industry earnings growth rate of 9.43%. CDNA earnings in the past year totalled $111.01 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.